You have 9 free searches left this month | for more free features.

shr4640

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hyperuricemia Trial (SHR4640)

Not yet recruiting
  • Hyperuricemia
  • SHR4640
  • (no location specified)
Jul 13, 2023

Hepatic Impairment Trial in Beijing (SHR4640)

Active, not recruiting
  • Hepatic Impairment
  • SHR4640
  • Beijing, Beijing, China
    Meixia Wang
Aug 9, 2022

Gout Trial in Shanghai (SHR4640, Allopurinol)

Recruiting
  • Gout
  • Shanghai, Shanghai, China
    RenJi Hospital, Shanghai JiaoTong University School Of Medicine
Jul 7, 2021

Healthy Subjects Trial (SHR4640)

Unknown status
  • Healthy Subjects
  • SHR4640
  • (no location specified)
Nov 5, 2020

Primary Gout, Hyperuricemia Trial (SHR4640)

Unknown status
  • Primary Gout
  • Hyperuricemia
  • SHR4640
  • (no location specified)
Oct 9, 2020

Gout Trial in Suzhou (Colchicine, Febuxostat, SHR4640)

Completed
  • Gout
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Aug 6, 2019

Hyperuricemia Trial in Shanghai (Placebo, SHR4640, benzbromarone)

Completed
  • Hyperuricemia
  • Placebo
  • +2 more
  • Shanghai, Shanghai, China
    Jiangsu Hengrui Medicine Co., Ltd.
Aug 5, 2019

Gout Trial in Sydney (SHR4640, Placebo)

Completed
  • Gout
  • SHR4640
  • Placebo
  • Sydney, New South Wales, Australia
    Atridia Pty Limited
Jul 2, 2018

Gout, Hyperuricemia Trial in Sydney (SHR4640)

Completed
  • Gout
  • Hyperuricemia
  • SHR4640
  • Sydney, New South Wales, Australia
    Atridia Pty Limited
Mar 20, 2018

Gout; Hyperuricemia Trial in Chongqing (SHR4640, )

Completed
  • Gout; Hyperuricemia
  • SHR4640
  • placebo
  • Chongqing, Chongqing, China
    The South West Hospital
Mar 29, 2017

Gout; Hyperuricemia Trial in Chongqing (SHR4640, Placebo)

Completed
  • Gout; Hyperuricemia
  • SHR4640
  • Placebo
  • Chongqing, Sichuan, China
    Southwest Hospital
Feb 26, 2017